Study: Simple scope exam cuts colon cancer deaths

May 21, 2012 MARILYNN MARCHIONE , AP Chief Medical Writer

A simple, cheaper exam of just the lower part of the bowel can cut the risk of developing colon cancer or dying of the disease, a large federal study finds.

Many doctors recommend a more complete test - colonoscopy - but many people refuse that costly, unpleasant exam. The new study shows that the simpler test, , can be a good option. Although it may seem similar to having a mammogram on just one breast, experts say that even a partial bowel exam is better than none.

As one put it, "the best test is the one that gets done."

The study was published online Monday by the and was to be presented at a conference in San Diego.

is the second leading cause of cancer deaths in the United States and the fourth worldwide. More than 143,000 new cases and 52,000 deaths from the disease are expected this year in the U.S. alone.

People ages 50 to 75 who are at average risk of are urged to get screened, but only about 60 percent do. Government advisers recommend one of three methods: annual stool blood tests, a sigmoidoscopy (SIG-moy-DAH-skuh-pee) every five years plus stool tests every three years, or a colonoscopy once a decade.

In a colonoscopy, a thin tube with a is guided through the . Growths can be removed and checked for cancer. Patients are sedated, but it requires drinking strong solutions the day before to clean out the bowel.

Sigmoidoscopy is not a popular choice in the United States but it's the one used most often in England. It also uses a thin scope and tiny camera, can be done in an ordinary doctor's office, requires much less bowel preparation and costs just $150 to $300 versus $1,000 to $2,000 for a colonoscopy.

One drawback: It's done without anesthesia. The test usually isn't painful, but patients feel cramping and some discomfort, said Dr. Durado Brooks, the American Cancer Society's colon cancer expert. It also sees only the lower one-third of the colon, "but that is an area where probably half of polyps and cancers develop," Brooks said.

The new study, led by Dr. Robert Schoen of the University of Pittsburgh Medical Center, tested how well it works.

From 1993 to 2001, about 155,000 people ages 55 to 75 were assigned to get the simple scope exam at the start of the study and three to five years later, or usual care - screening by any means only if they or their doctors wanted it done. Any patients with suspicious findings were sent for a colonoscopy.

After about 12 years of follow-up, there were 21 percent fewer cases of colon cancer and 26 percent fewer deaths from the disease in the group assigned to get sigmoidoscopy.

Of the cancers in that group, 243 were considered to have been caught by sigmoidoscopy (many others were found because of symptoms or other tests). Researchers estimate that 97 more would have been detected if colonoscopy had been the main screening method instead of the simpler scope exam, said study co-leader Dr. Christine Berg, chief of early detection research at the National Cancer Institute, which sponsored the research.

"My opinion is that there's no doubt that would be better in detecting more total cancers," she said. "A sigmoidoscopy could be used in situations where people are afraid of having the bowel prep," or when anesthesia is a risk, she said.

In the study, about half of the group assigned to usual care wound up getting some type of scope exam anyway. That was far more than study leaders expected, and it could have diminished the true benefit sigmoidoscopy gave to the screening group, Dr. John Inadomi of the University of Washington in Seattle wrote in an editorial in the medical journal.

A patient's choice of tests must be respected, he added. "In this case, the best test is the one that gets done."

Explore further: Study: Colonoscopy cuts colon cancer death risk

More information: New England Journal:

Screening guidelines:

Related Stories

Study: Colonoscopy cuts colon cancer death risk

February 22, 2012
(AP) -- Millions of people have endured a colonoscopy, believing the dreaded exam may help keep them from dying of colon cancer. For the first time, a major study offers clear evidence that it does.

Study finds sigmoidoscopy reduces colorectal cancer rates

May 21, 2012
Flexible sigmoidoscopy, a screening test for colorectal cancer that is less invasive and has fewer side effects than colonoscopy, is effective in reducing the rates of new cases and deaths due to colorectal cancer, according ...

Too many americans skipping colon cancer screening

March 2, 2012
(HealthDay) -- Approximately one in three U.S. adults between the ages of 50 and 75 who should be screened for colorectal cancer have not been, according to the American Society for Gastrointestinal Endoscopy.

Recommended for you

CAR-T immunotherapy may help blood cancer patients who don't respond to standard treatments

October 20, 2017
Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis is one of the first centers nationwide to offer a new immunotherapy that targets certain blood cancers. Newly approved ...

Researchers pinpoint causes for spike in breast cancer genetic testing

October 20, 2017
A sharp rise in the number of women seeking BRCA genetic testing to evaluate their risk of developing breast cancer was driven by multiple factors, including celebrity endorsement, according to researchers at the University ...

Study shows how nerves drive prostate cancer

October 19, 2017
In a study in today's issue of Science, researchers at Albert Einstein College of Medicine, part of Montefiore Medicine, report that certain nerves sustain prostate cancer growth by triggering a switch that causes tumor vessels ...

Gene circuit switches on inside cancer cells, triggers immune attack

October 19, 2017
Researchers at MIT have developed a synthetic gene circuit that triggers the body's immune system to attack cancers when it detects signs of the disease.

One to 10 mutations are needed to drive cancer, scientists find

October 19, 2017
For the first time, scientists have provided unbiased estimates of the number of mutations needed for cancers to develop, in a study of more than 7,500 tumours across 29 cancer types. Researchers from the Wellcome Trust Sanger ...

Researchers target undruggable cancers

October 19, 2017
A new approach to targeting key cancer-linked proteins, thought to be 'undruggable," has been discovered through an alliance between industry and academia.


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.